What is the current price / NAV of Tata India Pharma & Healthcare Fund?
The current NAV of Tata India Pharma & Healthcare Fund is ₹28.67, as of 20th March 2026.What are the returns of Tata India Pharma & Healthcare Fund?
The Tata India Pharma & Healthcare Fund was launched on 28th December 2015. This mutual fund's past returns are as follows:- 1 Year Returns: 0.51%
- 3 Year Returns: 22.76%
- 5 Year Returns: 15.25%
What are the top 5 sectoral holdings of Tata India Pharma & Healthcare Fund?
The top sectors Tata India Pharma & Healthcare Fund has invested in are as follows:- Pharmaceuticals | 56.31%
- Labs & Life Sciences Services | 35.54%
- Others | 4.60%
- Fertilizers & Agro Chemicals | 3.33%
- Miscellaneous | 0.20%
What are the top 5 holdings of Tata India Pharma & Healthcare Fund?
The top 5 holdings for Tata India Pharma & Healthcare Fund are as follows:- Sun Pharmaceutical Industries Ltd | 9.66%
- Max Healthcare Institute Ltd | 6.78%
- Divi's Laboratories Ltd | 5.94%
- Abbott India Ltd | 5.60%
- Healthcare Global Enterprises Ltd | 5.04%
What is the asset allocation of Tata India Pharma & Healthcare Fund?
The asset allocation for Tata India Pharma & Healthcare Fund is as follows:- Equity | 97.59%
- Cash & Equivalents | 2.41%
What is the AUM of Tata India Pharma & Healthcare Fund?
The AUM (i.e. assets under management) of Tata India Pharma & Healthcare Fund is ₹1239.57 Cr as of 20th March 2026.What is the expense ratio of Tata India Pharma & Healthcare Fund?
The expense ratio of Tata India Pharma & Healthcare Fund Plan is 2.11 as of 20th March 2026.What is the alpha ratio of Tata India Pharma & Healthcare Fund?
The alpha ratio for the Tata India Pharma & Healthcare Fund is 16.25
Alpha is the excess return of a fund compared to its expected return, based on its beta and the risk-free rate. Positive alpha indicates that the fund has outperformed its expected return, while negative alpha suggests underperformance.
What is the volatility or standard deviation of Tata India Pharma & Healthcare Fund?
The volatility or standard deviation for the Tata India Pharma & Healthcare Fund is 12.56
Standard deviation measures the volatility or risk associated with the returns of a mutual fund. A higher standard deviation indicates higher volatility, suggesting that the returns of the mutual fund are more spread out from the average. On the other hand, a lower standard deviation implies lower volatility and a more stable performance.
What is the sharpe ratio of Tata India Pharma & Healthcare Fund?
The Sharpe ratio for the Tata India Pharma & Healthcare Fund is -0.33
The Sharpe ratio is a measure of risk-adjusted return that evaluates the performance of a mutual fund, by adjusting for its risk. Higher Sharpe ratio indicates a better risk-adjusted performance. A positive Sharpe ratio indicates that the MF has provided a return in excess of the risk-free rate for the amount of risk taken. Conversely, a negative Sharpe ratio suggests that the MF did not adequately compensate for the risk.
What is the Sortino ratio of Tata India Pharma & Healthcare Fund?
The Sortino Ratio for the Tata India Pharma & Healthcare Fund is -0.03
The Sortino ratio of a mutual fund is a measure of its risk-adjusted return, considering only downside volatility. It helps investors evaluate how well a fund is performing relative to its downside risk. A higher Sortino ratio (value >1) means the fund generates better returns for the downside risk taken.
What is the Price to Earnings (PE) ratio of Tata India Pharma & Healthcare Fund?
The PE ratio of Tata India Pharma & Healthcare Fund is 44.16, while category PE ratio is 43.26.

Gains are treated as short-term capital gains and taxed at 20%
Gains are treated as long-term capital gains and taxed at 12.5%